Wealth Enhancement Trust Services’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
Wealth Enhancement Trust Services's PRME Position: Q3 2026 in Review
Wealth Enhancement Trust Services sold out of Prime Medicine (PRME) in Q3 2026, closing a stake of 3 shares — an estimated $11 sold.
Wealth Enhancement Trust Services first reported a position in PRME in Q2 2026 and held it in 1 quarter. The position peaked at $11 in Q2 2026. 185 funds tracked by Wall St. Rank hold PRME as of Q3 2026.
- Wealth Enhancement Trust Services reported no remaining Prime Medicine position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Trust Services sold 3 Prime Medicine shares in Q3 2026, an estimated $11.
- Wealth Enhancement Trust Services first reported a position in Prime Medicine in Q2 2026 and held it in 1 quarter.
- Wealth Enhancement Trust Services's Prime Medicine position peaked at $11 in Q2 2026.
- 185 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.